Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer-Reference-Cited by-同舟云学术

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Published:2003-07-21 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Shelley Mike,Court J B,Kynaston H,Wilt Timothy,Coles Bernadette,Mason Malcolm

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003231/epdf/full

Reference42 articles.

1. A randomised multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guérin;Krege;Journal of Urology,1996

2. Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

3. 5-Year follow-up of a randomised prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma;Malmstrom;Journal of Urology,1999

4. A multicenter and randomised prospective study comparing three intravesical therapies, two with Bacillus Calmette-Guerin and one with mitomycin C chemotherapy in medium and low risk superficial bladders tumours;Nogueira March;Eurpean Urology,2001

5. Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guerin) in superficial bladder cancer;Rintala;European Urology,1991

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bibliometric insights into drug resistance in bladder cancer: Two decades of progress (1999–2022);Heliyon;2024-06

2. Hemorrhagic cystitis in gastric cancer after nanoparticle albumin-bound paclitaxel: A case report;World Journal of Gastrointestinal Oncology;2024-03-15

3. Comparing Clinical Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with T1 High Grade Bladder Cancer;2023-09-15

4. The comparison of efficacy between the connaught and tice strains of bacillus calmette-guérin in patients with non-muscle-invasive bladder cancer in Taiwan;Urological Science;2022

5. Clinical Research Progress of Non-Muscular Invasive Bladder Cancer;Advances in Clinical Medicine;2022